Drugs / Xulin Jiangu granules
last change Dec 2021 re-read 2 minutes ago

Xulin Jiangu granules

Developed for
postmenopausal osteoporosis
Investigated by
Fujian Academy of Traditional Chinese Medicine

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT03563235 Sep 2019 → Sep 2021 postmenopausal osteoporosis Fujian Academy of Traditional Chinese Medicine Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Xulin Jiangu granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT03563235
Route Oral “by mouth” NCT03563235